Jonathan Wogel Email & Phone Number

England, United Kingdom

Winsford, Cheshire, Gb

Bristol, England, Gb

Non Executive Chair at Zentraxa - Start up biotech company developing novel, synthetic bio-polymers & bio-materials via a bespoke platform.Member of the Board & Executive team; development & nurturing of investor relations; mentoring/leadership in developing governance models; maximising both funding and commercial/JDA & licensing opportunities; development of strategic commercial proposition for target markets

Manchester, England, Gb

Leading the conversation and driving innovation in clinical trials delivery.From trial design modelling in minutes, not days, that empowers faster & better recruitment to enrolment in an unparalleled trials platform with real time SAE monitoring & endpoint analysis.Discovering more. Delivering better.

London, United Kingdom, Gb

Biotech, medical devices, pharma, healthcare and pharma services M&A and post integration consulting , offering specialist support from confirmatory/bid Due Diligence to post acquisition planning and delivery.

Interim Business Leader & Non-Executive Director (NED) - enterprising & commercially-led, with extensive experience of developing value-driven strategies to deliver large-scale transformational change and success.Internationally-experienced - having engaged across consulting, FMCG, pharmaceutical & corporate sectors.Collaborative approach to strategic business direction - engaging with senior stakeholders, investors and senior executives at up to C-level to build business plans, strategies, operating models and realise growth. Inspiring as a Business Leader - leveraging an ‘open’ management style to effectively empower and enable multi-functional, high-performing teams of up to 2500+ staff across 20 countries globally, and diverse cultures. Experience of business development through global launches of 50+ FMCG, pharma, medical device and biotech products, and highly-successful leadership of a series of 30+ major M&A and JV licensing deals.Highly accomplished - able to lead and grow multinational businesses from £20m to £500m+ and effectively turnaround organisations to improve profitability, sustainable growth and overall EBDITDA performance.

Comber, Northern Ireland, Gb

Paris, Fr

Full P&L responsibility for MEA/India business unit. Sales, marketing, Finance/contracting/pricing, logistics, BD and distributor management. Geographic expansion planning (India, Africa, support to SE Asia) HECON strategy and project management.

Minneapolis, Mn, Us

Global commercial, Therapy development, Product development, MedEd, & BD strategy. Responsible for P&L, annual operating plan.

Paris, France, Fr

Deerfield, Illinois, Us

Haemodialysis product & market development strategy. Integration of Althin products post acquisition. Home Haemo strategy & support to technical development.